SHANGHAI – Last week, a day before CPhI's China Pharma Week kicked off in Shanghai with thousands of foreign drug company reps in attendance, China's drug industry received some welcome news. The CFDA was accepted as a regulatory member to the International Council of Harmonization (ICH), an important step in China's ongoing journey to become a globally leading supplier and market for quality pharmaceuticals.